Zio ECG Utilization Software (ZEUS) System vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Viz.ai

AI Verdict

ZEUS is designed for the diagnosis and management of cardiac arrhythmias through continuous ECG data analysis from wearable monitors, primarily serving cardiology and primary care. In contrast, Viz AAA focuses on the rapid detection and triage of suspected Abdominal Aortic Aneurysms from CT angiography scans, targeting emergency medicine, radiology, and vascular surgery workflows. While both are AI-powered cardiology tools, they address different cardiac conditions and utilize distinct data sources and clinical applications.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if your primary need is continuous, long-term ECG monitoring for patients with suspected or known cardiac arrhythmias. This AI-powered, cloud-based platform provides comprehensive analysis of up to 14 days of ECG data from wearable Zio monitors, aiding in the diagnosis and management of various heart rhythm disorders.

View Zio ECG Utilization Software (ZEUS) System →

Choose Viz AAA if…

Choose Viz AAA if your focus is on the rapid detection and urgent management of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. This AI-powered solution is specifically designed to automatically identify AAA, prioritize cases, and facilitate immediate care team communication, significantly accelerating diagnosis and coordination for time-sensitive vascular conditions.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System Viz AAA
Pricing Unknown Enterprise (hospital/health system)
Deployment Cloud-based. Cloud-based, integrates with PACS and EHR systems.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

Tool A (ZEUS) prioritizes patient usability with its 'wear and forget' Zio monitor, featuring a simple 'peel and stick' application and a water-resistant design, which enhances patient compliance and data quality. The accompanying MyZio app further simplifies symptom logging for patients.

Clinical Value

Viz AAA

Both tools offer significant clinical value with FDA clearance. However, Tool B (Viz AAA) is the first FDA-cleared AI solution for detecting and triaging suspected Abdominal Aortic Aneurysm, a time-sensitive and life-threatening condition. Its ability to accelerate diagnosis and care coordination for such an acute pathology provides a critical and immediate clinical impact.

Pricing & Value

Tie

Both tools lack public pricing transparency, making a direct comparison of cost-effectiveness challenging. While Tool A provides information on insurance coverage and patient assistance programs, and studies suggest potential cost savings for healthcare systems, Tool B offers an 'Aneurysm Calculator' to estimate economic impact without revealing specific pricing tiers.

Enterprise Readiness

Viz AAA

Both tools demonstrate strong enterprise readiness with cloud deployment, HIPAA compliance, and FDA clearance. However, Tool B (Viz AAA) explicitly details a broader range of security and compliance certifications, including SOC 2 Type II, multiple ISO standards, and GDPR compliance, and provides a dedicated Trust Center for comprehensive documentation, indicating a more robust and transparent approach to enterprise security and data governance.

Innovation

Viz AAA

While Tool A innovates in long-term, patient-friendly cardiac monitoring, Tool B stands out as the 'first FDA-cleared' AI solution for AAA detection and triage, addressing a critical and time-sensitive condition. Its integrated platform for real-time alerts and care coordination, along with the ability for health systems to build custom AI care pathways via 'Viz Agent Studio,' demonstrates a broader and more adaptable innovation strategy.

Support & Docs

Viz AAA

Both companies offer good support and documentation. However, Tool B (Viz AAA) provides more extensive resources, including a comprehensive Help Center, 24/7 urgent phone support, and a dedicated 'Viz Academy' for training. Its transparent Trust Center also offers direct access to detailed compliance and security documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System Viz AAA
Name Zio ECG Utilization Software (ZEUS) System Viz AAA
Company iRhythm Technologies Viz.ai
Primary Function Analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.
Target Specialties Cardiology, Family Medicine, Internal Medicine Emergency Medicine, Radiology, Vascular Surgery
Core AI Function AI algorithm for arrhythmia detection and classification; Proprietary deep-learned algorithms. AI-powered automatic detection of suspected AAA; Automated triage and prioritization of cases.
Data Source for Analysis Continuous ECG data from wearable Zio monitors CT angiography scans

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System aids physicians in the diagnosis and management of cardiac arrhythmias by analyzing continuous ECG data from wearable Zio monitors. Viz AAA is designed for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans to accelerate diagnosis and care coordination.
The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data collected from wearable Zio monitors. Viz AAA analyzes CT angiography scans for the detection of suspected Abdominal Aortic Aneurysm (AAA).
The Zio ECG Utilization Software (ZEUS) System integrates via the ZioSuite web portal and mobile application, and offers HL7-based EHR integration, providing comprehensive end-of-wear reports for physician review. Viz AAA integrates into existing hospital workflows, provides real-time alerts to care teams, and offers a HIPAA-compliant communication platform with mobile access to high-fidelity imaging and patient information.
The Zio ECG Utilization Software (ZEUS) System is designed for Cardiology, Family Medicine, and Internal Medicine. Viz AAA is primarily intended for Emergency Medicine, Radiology, and Vascular Surgery.
The Zio ECG Utilization Software (ZEUS) System provides the ZioSuite web portal and mobile application for healthcare professionals to review reports. Viz AAA includes a HIPAA-compliant communication platform for multidisciplinary teams, real-time alerts, and mobile access to imaging and patient information to accelerate treatment decisions.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.